GSFTX
Price
$33.05
Change
+$0.30 (+0.92%)
Updated
Dec 20 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

GSFTX vs RMFCX

Header iconGSFTX vs RMFCX Comparison
Open Charts GSFTX vs RMFCXBanner chart's image
Columbia Dividend Income Inst
Price$33.05
Change+$0.30 (+0.92%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
GSFTX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSFTX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSFTX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. GSFTX (41.5B). GSFTX (1.74) and RMFCX (1.69) have matching dividends . GSFTX was incepted earlier than RMFCX: GSFTX (27 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. GSFTX (17.00). RMFCX has a lower initial minimum investment than GSFTX: RMFCX (250) vs GSFTX (2000). GSFTX (11.59) and RMFCX (11.11) have marching annual gain over last year. GSFTX return over 5 years is better than : 45.68 vs. RMFCX (37.80).
GSFTXRMFCXGSFTX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years23 years-
Gain YTD10.6389.921107%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets41.5B102B41%
Annual Yield % from dividends1.741.69103%
Returns for 1 year11.5911.11104%
Returns for 3 years13.9812.38113%
Returns for 5 years45.6837.80121%
Returns for 10 years91.7959.36155%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA